The article you requested is
Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia
Henry A. Nasrallah, MD; Matcheri S. Keshavan, MD; Francine M. Benes David, MD; L. Braff Alan I. Green, MD; Rachel E. Gur John M. Kane, MD; Diana O. Perkins , MD, MPH; Peter J. Weiden, MD; Daniel R. Weinberger, MD; Christoph U. Correll, MD
J Clin Psychiatry 2009;70(suppl 1):4-46
© Copyright 2015 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Article Abstract
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
In mid-February 2008, a panel of 10 nationally recognized schizophrenia research experts was
assembled in a Schizophrenia Summit to focus on controversies that exist in treating patients with
schizophrenia. The current literature related to the diagnosis and etiopathology of schizophrenia was
evaluated regarding the identification of a prodromal phase, brain changes, cognitive impairments,
genetic factors, and use of neuroimaging in patients with schizophrenia.